-
Signature
-
/s/ Nisha Antony, as Attorney-in-Fact
-
Stock symbol
-
CRWV
-
Transactions as of
-
Nov 25, 2025
-
Transactions value $
-
-$255,768
-
Form type
-
4
-
Date filed
-
11/28/2025, 07:16 PM
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Agrawal Nitin |
Chief Financial Officer |
C/O COREWEAVE, INC., 290 WEST MT. PLEASANT AVENUE, SUITE 4100, LIVINGSTON |
/s/ Nisha Antony, as Attorney-in-Fact |
2025-11-28 |
0002058038 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
CRWV |
Class A Common Stock |
Sale |
-$19.3K |
-290 |
-0.19% |
$66.62 |
151K |
Nov 25, 2025 |
Direct |
F1, F2 |
| transaction |
CRWV |
Class A Common Stock |
Sale |
-$20.3K |
-300 |
-0.2% |
$67.51 |
151K |
Nov 25, 2025 |
Direct |
F1, F3 |
| transaction |
CRWV |
Class A Common Stock |
Sale |
-$20.6K |
-300 |
-0.2% |
$68.75 |
150K |
Nov 25, 2025 |
Direct |
F1, F4 |
| transaction |
CRWV |
Class A Common Stock |
Sale |
-$63.4K |
-900 |
-0.6% |
$70.43 |
149K |
Nov 25, 2025 |
Direct |
F1, F5 |
| transaction |
CRWV |
Class A Common Stock |
Sale |
-$118K |
-1.65K |
-1.1% |
$71.38 |
148K |
Nov 25, 2025 |
Direct |
F1, F6 |
| transaction |
CRWV |
Class A Common Stock |
Sale |
-$14.4K |
-200 |
-0.14% |
$72.04 |
148K |
Nov 25, 2025 |
Direct |
F1, F7 |
| holding |
CRWV |
Class A Common Stock |
|
|
|
|
|
116K |
Nov 25, 2025 |
By Spouse |
F8 |
| holding |
CRWV |
Class A Common Stock |
|
|
|
|
|
58K |
Nov 25, 2025 |
By Yosemite 2025 GRAT |
F9 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: